Idiopathic Childhood Nephrotic Syndrome

Objective: To predict the role of clinical risk factors and urinary β2-microglobulin levels as a biomarker for steroid-resistant nephrotic syndrome. Study Design: Quasi-experimental study.

[1]  Jingyuan Xie,et al.  New risk score for predicting steroid resistance in patients with focal segmental glomerulosclerosis or minimal change disease , 2020, Clinical Proteomics.

[2]  D. Gipson,et al.  IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome , 2020, Pediatric Nephrology.

[3]  D. Geary,et al.  Predicting and Defining Steroid Resistance in Pediatric Nephrotic Syndrome Using Plasma Metabolomics , 2019, Kidney international reports.

[4]  S. Pardede,et al.  Tubular Injury in Children with Steroid-resistant Nephrotic Syndrome , 2019 .

[5]  A. Sadaf,et al.  Clinicopathological profile of pediatric renal biopsies at a tertiary care hospital, Pakistan. , 2018, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

[6]  A. Anarat,et al.  Long-Term Outcome of Steroid-Resistant Nephrotic Syndrome in Children. , 2017, Journal of the American Society of Nephrology : JASN.

[7]  A. Sinha,et al.  Mycophenolate mofetil is inferior to tacrolimus in sustaining remission in children with idiopathic steroid-resistant nephrotic syndrome. , 2017, Kidney international.

[8]  S. Uwaezuoke.  The role of novel biomarkers in childhood idiopathic nephrotic syndrome: a narrative review of published evidence , 2017, International journal of nephrology and renovascular disease.

[9]  L. Peruzzi,et al.  The Italian Society for Pediatric Nephrology (SINePe) consensus document on the management of nephrotic syndrome in children: Part I - Diagnosis and treatment of the first episode and the first relapse , 2017, Italian Journal of Pediatrics.

[10]  R. Mak,et al.  Steroid-resistant nephrotic syndrome: past and current perspectives , 2017, Pediatric health, medicine and therapeutics.

[11]  A. Zagury,et al.  Steroid-resistant idiopathic nephrotic syndrome in children: long-term follow-up and risk factors for end-stage renal disease. , 2013, Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia.

[12]  E. Girardin,et al.  Urinary low-molecular-weight protein excretion in pediatric idiopathic nephrotic syndrome , 2013, Pediatric Nephrology.

[13]  J. Kazi,et al.  The Spectrum of Histopathological Lesions in Children Presenting with Steroid-Resistant Nephrotic Syndrome at a Single Center in Pakistan , 2012, TheScientificWorldJournal.

[14]  M. Adhikari,et al.  Steroid-resistant nephrotic syndrome: the influence of race on cyclophosphamide sensitivity , 2006, Pediatric Nephrology.

[15]  T. Libermann,et al.  Urine proteomic profiling of pediatric nephrotic syndrome , 2006, Pediatric Nephrology.

[16]  P. Vallés,et al.  Follow-up of steroid-resistant nephrotic syndrome: tubular proteinuria and enzymuria , 2000, Pediatric Nephrology.

[17]  H. Coovadia,et al.  Comparison of noninvasive methods for distinguishing steroid-sensitive nephrotic syndrome from focal glomerulosclerosis. , 1997, The Journal of laboratory and clinical medicine.

[18]  G. Ozbay,et al.  Urinary N-Acetyl-β-D-Glucosaminidase and β2-Microglobulin Excretion in Primary Nephrotic Children , 1996 .

[19]  R. Portman,et al.  Use of beta 2 microglobulin to diagnose tubulo-interstitial renal lesions in children. , 1986, Kidney international.